(Date:12/1/2009)...ould identify those who would benefit from liver s...ESDAY, Dec. 1 (HealthDay News) -- A CT scan of liv...r may help predict overall survival after chemothe...(Avastin) to cytotoxic chemotherapy has been shown...olorectal cancer and to produce better results in ...
(Date:12/1/2009)... Practitioners of any medi...nscription are breathing a sigh of relief this wee...Phone. The application, released over the holiday...anscribe voice recordings to do so quickly and sea... (PRWEB) December 1, 2009 -- The ...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog...
(Date:12/1/2009)..., , FORT LAUDERDALE, Fla., Dec. 1 /PRNews... of patient enrollment in the randomized clinical ...g Stent (Combo Stent). ,, A prospective, random... E valuation of an ablu M inal sirolimus coat ... patients at up to 20 sites in Asia, Australia, Eu...
(Date:12/1/2009)... Montreal, December 1, 2009 A Universit de Montra...arch Center on Family Violence and Violence Agains...ffects of pornography on men. "We started our rese...onsumed pornography. We couldn,t find any," says S...professor at the School of Social Work. , "The ...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Are the effects of pornography negligible? 2